Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/2003
03/06/2003WO2003018743A2 Emu-based formulations for wound treatment
03/06/2003WO2003018640A2 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids
03/06/2003WO2003018619A2 Antimicrobial and anti-inflammatory peptides
03/06/2003WO2003018591A1 Novel pseudolaric acid-b derivatives, their preparation and pharmaceutical compositions
03/06/2003WO2003018579A1 Alkyne-aryl phosphodiesterase-4 inhibitors
03/06/2003WO2003018576A1 New piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity
03/06/2003WO2003018574A1 Rapamycin dialdehydes
03/06/2003WO2003018568A2 Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof
03/06/2003WO2003018556A1 Piperidine derivatives useful as modulators of chemokine receptor activity
03/06/2003WO2003018545A1 24-sulfur-substituted analogs of 1α,25-dihydroxy vitamin d¿3?
03/06/2003WO2003018535A2 Novel aminobenzoephenones
03/06/2003WO2003018515A2 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
03/06/2003WO2003018496A1 Antimicrobial, anti-inflammatory, wound-healing glass powder and use thereof
03/06/2003WO2003018495A1 Water-insoluble, antimicrobial silicate glass and use thereof
03/06/2003WO2003018049A2 Use of milk serum apoproteins in the prophylaxis or treatment of microbial or viral infection
03/06/2003WO2003018044A1 New drug
03/06/2003WO2003018033A1 Use of fucans in the treatment of adhesions, arthritis and psoriasis
03/06/2003WO2003018020A1 Jnk inhibitors
03/06/2003WO2003018000A1 Novel ascorbic acid compounds, methods of synthesis and application
03/06/2003WO2003017949A2 Novel synthetic ganglioside derivatives and compositions thereof
03/06/2003WO2003017946A2 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
03/06/2003WO2003017941A2 Flexible applicator for applying oil-in-water emulsion with improved stability
03/06/2003WO2003017939A2 Piperazinone compounds as anti-tumor and anti-cancer agents and methods of treatment
03/06/2003WO2003017935A2 Human antibodies specific for interleukin 15 (il-15)
03/06/2003WO2003017917A2 Use of microbiology non-viral substances for treating acne
03/06/2003WO2003017824A2 Method and apparatus for acne treatment
03/06/2003WO2002096367A3 Targeted multivalent macromolecules
03/06/2003WO2002086069A3 Secreted proteins
03/06/2003WO2002083066A3 Amino acid complexes of c-aryl glucosides for treatment of diabetes and method
03/06/2003WO2002066516A3 Antibodies that bind both bcma and taci
03/06/2003WO2002060501A3 Hydrogel wound dressing,preparation and use thereof
03/06/2003WO2002055507A8 1-dimercaptoalkylquinazolin-2,4(1h,3h)-diones as matrix metalloproteinase (mmp) inhibitors
03/06/2003WO2002049605A3 Methods and compositions for protecting and restoring skin using selective mmp inhibitors
03/06/2003WO2002034726A9 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
03/06/2003WO2002028481A3 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
03/06/2003WO2002020516A1 Novel crystals of 1,3,4-oxadiazole derivative, process for producing the crystals and medicines containing the same as the active ingredient
03/06/2003WO2001092304A3 Transporters and ion channels
03/06/2003WO2001077146A3 Compounds and methods for modulating endothelial cell adhesion
03/06/2003US20030045686 Mutein polypeptide for use in the treatment of hypoxia and ischemic related tissue damages
03/06/2003US20030045585 Treatment of psoriasis
03/06/2003US20030045576 Composition for pain mediation and apparatus and method of use thereof
03/06/2003US20030045565 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
03/06/2003US20030045556 Aryl-N-cyanoguanidines and methods related thereto
03/06/2003US20030045552 Isoindole-imide compounds, compositions, and uses thereof
03/06/2003US20030045546 Anticancer agents
03/06/2003US20030045544 Bactericides for the oral region of animals using 3-carboxy-4-oxo quinoline or 1,8-naphthyridine derivatives or 1-cyclopropyl-3-carboyx-4-oxo quinolizine derivatives
03/06/2003US20030045521 Sulfohydroxamic acids and sulfohydroxamates and their use as MEK inhibitors
03/06/2003US20030045516 Chemokine receptor antagonists and methods of use therefor
03/06/2003US20030045505 Oligosaccharide having at least a D-galactose unit bound by an alpha (1-6) bond with a sucrose unit; second component is a molecule positively charged at physiological pH and that promotes pinocytosis or membrane penetration
03/06/2003US20030045490 Therapeutic antisense phosphodiesterase inhibitors
03/06/2003US20030045478 Treating diseases such as cardiac and cerebral ischemia or reperfusion injury, sepsis and bacterial meningitis.
03/06/2003US20030045461 Composition and methods of esterified nitroxides gated with carboxylic acids
03/06/2003US20030045460 Orally administered peptides to ameliorate atherosclerosis
03/06/2003US20030044863 Diagnosing cancer in humans; obtain tissue sample, detect invasive complexes associated tissus, evaluate for cancer
03/06/2003US20030044452 Composition for topical administration
03/06/2003US20030044449 Physiologically functional foods or cosmetics containing sphingoglycolipids and processes for their production
03/06/2003US20030044446 A multilayered film comprising a first, water-soluble adhesive layer to be placed in contact with a mucosal surface and a second, water-erodible non-adhesive backing layer that controls residence time; drug delivery from mouth
03/06/2003US20030044439 Treatment of skin with adenosine or adenosine analog
03/06/2003US20030044438 Adapted for improving skin ageing and/or photoageing signs, which cutaneous signs are directly a result of a chronic micro-inflammatory process induced by repeated UV exposures
03/06/2003US20030044366 Mixture of colorant, silica and water
03/06/2003US20030044363 Protective coatings for skin, hair
03/06/2003US20030042435 Quartz schist comprising oxides of silicon, aluminum, and iron
03/06/2003CA2459974A1 Emu-based formulations for wound treatment related application information
03/06/2003CA2458565A1 New angiogenesis inhibitors based on soluble cd44 receptor hyaluronic acid binding domain
03/06/2003CA2458344A1 Ascorbic acid derivatives, methods of synthesis and pharmaceutical use thereof
03/06/2003CA2458131A1 Jnk activation inhibitor
03/06/2003CA2457885A1 Antimicrobial and anti-inflammatory peptides
03/06/2003CA2457846A1 Use of heparinoid derivatives for treating and diagnosing diseases that can be treated by heparinoids
03/06/2003CA2457794A1 Novel synthetic ganglioside derivatives and compositions thereof
03/06/2003CA2457590A1 Method and apparatus for acne treatment
03/06/2003CA2457532A1 Non-oxidatively metabolized compounds and compositions, synthetic pathways therefor, and uses thereof
03/06/2003CA2455883A1 Anti-cancer and wound healing compounds
03/06/2003CA2455311A1 Rapamycin dialdehydes
03/06/2003CA2449515A1 Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders
03/06/2003CA2421499A1 Novel crystals of 1,3,4-oxadiazole derivative, process for producing the same and pharmaceutical agent containing the same as active ingredient
03/05/2003WO2002020566A2 NOVEL MMP-2 DERIVATIVES FOR USE AS INHIBITORS OF INTEGRIN αVβ¿3?
03/05/2003EP1288299A2 TRNA synthetase
03/05/2003EP1288264A1 Gelling composition
03/05/2003EP1288227A1 Coactivator of nuclear receptors
03/05/2003EP1288221A1 Oligopeptides
03/05/2003EP1288206A1 Substituted benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors
03/05/2003EP1288205A1 Novel phenylalanine derivatives
03/05/2003EP1287825A1 Blends comprising a substituted fatty acid or a derivative thereof
03/05/2003EP1287130A2 Mammalian cytokine receptor subunit proteins, related reagents and methods
03/05/2003EP1287121A2 Extracellular domain of ryk protein for regulating angiogenesis
03/05/2003EP1287035A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/05/2003EP1287020A2 Cancer diagnosis and assays for screening anti-cancer agents
03/05/2003EP1287019A1 Therapeutic approaches to diseases by suppression of the nurr subfamily of nuclear transcription factors
03/05/2003EP1287017A1 2-substituted pregna-1,3,5(10)-triene and chola-1,3,5(10)-triene derivatives and their biological activity
03/05/2003EP1287015A1 Extracellular matrix polynucleotides, polypeptides, and antibodies
03/05/2003EP1286995A1 2,7-naphthyridine derivatives
03/05/2003EP1286989A2 Prodrug of an ice inhibitor
03/05/2003EP1286975A1 Biclyclic cyclohexylamines and their use as nmda receptor antagonists
03/05/2003EP1286972A1 Pyrimidine compounds
03/05/2003EP1286964A1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
03/05/2003EP1286962A1 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds
03/05/2003EP1286693A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
03/05/2003EP1286691A2 Methods for treatment of diseases associated with inflammation under non-ischemic conditions
03/05/2003EP1286690A2 Use of alpha-msh and epo for preventing or treating ischemic conditions
03/05/2003EP1286679A1 Skin treatment preparation
1 ... 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 ... 1065